Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
K
284620
vs
K
KOSPI 200
Over the past 12 months, Kainos Medicine Inc has underperformed KOSPI 200, delivering a return of 0% compared to KOSPI 200's +108% growth.
Stocks Performance
284620 vs KOSPI 200
Performance Gap
284620 vs KOSPI 200
Performance By Year
284620 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Kainos Medicine Inc
Glance View
Kainos Medicine, Inc. engages in the research and development of pharmaceutical products. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2018-06-08. The firm is engaged in the research and development of degenerative brain disease treatments, antiviral drugs, anticancer drugs and other products. In addition, the Company is engaged in the research and development of Parkinson's disease drugs, AIDS drugs, blood anticancer drugs and other products.